NCT06045806 2026-03-05
KarMMa-9
Celgene
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT03601078 2026-03-04
KarMMa-2
Celgene
Phase 2 Completed
NCT05393804 2026-02-17
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT06357754 2026-01-22
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Bristol-Myers Squibb
Recruiting